We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance – News and Features

News

Unmasked Enzyme Offers Hope of Effective Diabetes Treatment

The teams at two MRC institutes have determined the structure of the enzyme that regulates cellular energy levels.
News

Plexera Bioscience and MitoSciences Inc. Announce Collaboration on Mitochondrial Array

Letter of intent outlines commercial path for mitochondrial antibody arrays for use on the ProteomicProcessor™.
News

InnoMed Drug Safety Experts begin Mechanistic Investigations

Scientists from the Innovative Medicines for Europe consortium are planning a series of critical experiments aimed at improving drug safety.
News

Gene Logic Collaborates with FDA to Explore Genomic Data Quality Metrics Related to Drug Candidate Safety and Effectiveness

Gene Logic to share quality control methods and metrics with the FDA that may be useful in better understanding disparate genomic data sent as part of regulatory submissions.
News

Celsis Adds Drug Development Services to Growing Services Portfolio

The new service offerings include ADME-Tox studies and preclinical and clinical CMC development services.
News

Optimata Granted Patent for Granulopoiesis-Modelling System

Optimata has been granted a U.S. Patent for a system and method that models granulopoiesis and it can now optimize cancer drug development with less toxicity.
News

Entelos Acquires Iconix Biosciences

Iconix’s technology will add new capabilities for translational medicine and for finding new uses for existing drugs and drug combinations.
News

Mesoblast's Stem Cells Protect Knee Cartilage in Osteoarthritis

Mesoblast's allogeneic, or donor unrelated, adult stem cells protected knee joint cartilage against destruction in osteoarthritis preclinical trials.
News

Whatman Provides FTA Elute to NCRI Prostate Cancer Biomarker Study

MRC clinical trials unit to implement Whatman FTA Elute in DNA collection and preparation kits to study genetic markers affecting prostate cancer treatments.
News

Abraxis BioScience and The Scripps Research Institute Enter Exclusive Licensing Agreement

The agreement aims at the the worldwide development and commercialization of a epothilone therapeutic for the treatment of cancer.
Advertisement